Roche returns to Chinese biotech MediLink for another ADC pact

Roche has signed another licensing deal with its China-based partner MediLink, this time focused on an antibody-drug conjugate for solid tumors that targets B7-H3. The Swiss drugmaker will obtain exclusive rights to MediLink’s drug, called ...